van Houte Hans

Nurix Therapeutics, Inc. · Chief Financial Officer

van Houte Hans is listed in public filings as officer: Chief Financial Officer. This van Houte Hans insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Nurix Therapeutics, Inc. (NRIX). Investors use van Houte Hans's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Nurix Therapeutics, Inc.NRIX$223k13.5k sharesSellMay 5, 2026$16.58--
Nurix Therapeutics, Inc.NRIX$10.0k582 sharesSellMay 5, 2026$17.18--